Professor John Tagg recently spoke with Dave Asprey of Bulletproof Radio about his years of dedicated research and development of BLIS K12TM and BLIS M18TM that began at Otago University and then lead to the establishment of BLIS Technologies.
This insightful podcast talks about how it all began, with John suffering from Group A Strep throat infections as a child and his journey to finding a probiotic solution.
Listen here:
Meet us at Vitafoods Asia 2024 where we will be presenting our latest probiotic innovations and clinical research.
We’re partnering with the IPA World Congress + Probiota Americas this June. Join us in Salt Lake City to dive into the world of microbiome science and business.
Upper respiratory illnesses, such as the common cold and flu, have a significant impact on our daily lives. To combat these upper respiratory illnesses naturally, a potential solution may be closer than you think: BLIS K12™. T
Gum disease (periodontitis) is one of the most prevalent chronic health conditions globally — yet it often goes undetected until it’s advanced.
Scientific innovation is a team effort, and at BLIS, we’re proud to have a diverse group of scientists driving our research forward.
Our whitepaper delves into the science of probiotics and their role in reshaping the way we manage autoimmune health.
